 | • レポートコード：QFJ1-4520 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、鼻咽頭癌分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・鼻咽頭癌分子診断の市場動向 ・企業の競争状況、市場シェア ・鼻咽頭癌分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・鼻咽頭癌分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・鼻咽頭癌分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・鼻咽頭癌分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・鼻咽頭癌分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鼻咽頭癌分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・鼻咽頭癌分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kingmed、Inmedi、ApexHealth、SinoMD、Premed、Annoroad、Topgen、Geneis、Unitedgene、Easydiagnosis） ・結論 |
A molecular approach for diagnosing nasopharyngeal carcinoma
Market Analysis and Insights: Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market
The global Molecular Diagnosis of Nasopharyngeal Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis of Nasopharyngeal Carcinoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis of Nasopharyngeal Carcinoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis of Nasopharyngeal Carcinoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis of Nasopharyngeal Carcinoma market.
Global Molecular Diagnosis of Nasopharyngeal Carcinoma Scope and Market Size
Molecular Diagnosis of Nasopharyngeal Carcinoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis of Nasopharyngeal Carcinoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Kingmed
Inmedi
ApexHealth
SinoMD
Premed
Annoroad
Topgen
Geneis
Unitedgene
Easydiagnosis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Perspective (2016-2027)
2.2 Molecular Diagnosis of Nasopharyngeal Carcinoma Growth Trends by Regions
2.2.1 Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis of Nasopharyngeal Carcinoma Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis of Nasopharyngeal Carcinoma Industry Dynamic
2.3.1 Molecular Diagnosis of Nasopharyngeal Carcinoma Market Trends
2.3.2 Molecular Diagnosis of Nasopharyngeal Carcinoma Market Drivers
2.3.3 Molecular Diagnosis of Nasopharyngeal Carcinoma Market Challenges
2.3.4 Molecular Diagnosis of Nasopharyngeal Carcinoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Nasopharyngeal Carcinoma Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Nasopharyngeal Carcinoma Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue
3.4 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue in 2020
3.5 Molecular Diagnosis of Nasopharyngeal Carcinoma Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Nasopharyngeal Carcinoma Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Nasopharyngeal Carcinoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis of Nasopharyngeal Carcinoma Breakdown Data by Type
4.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnosis of Nasopharyngeal Carcinoma Breakdown Data by Application
5.1 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (2016-2027)
6.2 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type
6.2.1 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application
6.3.1 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country
6.4.1 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (2016-2027)
7.2 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type
7.2.1 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application
7.3.1 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country
7.4.1 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type
9.2.1 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application
9.3.1 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country
9.4.1 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.1.4 Kingmed Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.1.5 Kingmed Recent Development
11.2 Inmedi
11.2.1 Inmedi Company Details
11.2.2 Inmedi Business Overview
11.2.3 Inmedi Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.2.4 Inmedi Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.2.5 Inmedi Recent Development
11.3 ApexHealth
11.3.1 ApexHealth Company Details
11.3.2 ApexHealth Business Overview
11.3.3 ApexHealth Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.3.4 ApexHealth Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.3.5 ApexHealth Recent Development
11.4 SinoMD
11.4.1 SinoMD Company Details
11.4.2 SinoMD Business Overview
11.4.3 SinoMD Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.4.4 SinoMD Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.4.5 SinoMD Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.5.4 Premed Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.5.5 Premed Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.6.4 Annoroad Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.6.5 Annoroad Recent Development
11.7 Topgen
11.7.1 Topgen Company Details
11.7.2 Topgen Business Overview
11.7.3 Topgen Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.7.4 Topgen Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.7.5 Topgen Recent Development
11.8 Geneis
11.8.1 Geneis Company Details
11.8.2 Geneis Business Overview
11.8.3 Geneis Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.8.4 Geneis Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.8.5 Geneis Recent Development
11.9 Unitedgene
11.9.1 Unitedgene Company Details
11.9.2 Unitedgene Business Overview
11.9.3 Unitedgene Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.9.4 Unitedgene Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.9.5 Unitedgene Recent Development
11.10 Easydiagnosis
11.10.1 Easydiagnosis Company Details
11.10.2 Easydiagnosis Business Overview
11.10.3 Easydiagnosis Molecular Diagnosis of Nasopharyngeal Carcinoma Introduction
11.10.4 Easydiagnosis Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
11.10.5 Easydiagnosis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Regions (2016-2021)
Table 10. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Regions (2022-2027)
Table 12. Molecular Diagnosis of Nasopharyngeal Carcinoma Market Trends
Table 13. Molecular Diagnosis of Nasopharyngeal Carcinoma Market Drivers
Table 14. Molecular Diagnosis of Nasopharyngeal Carcinoma Market Challenges
Table 15. Molecular Diagnosis of Nasopharyngeal Carcinoma Market Restraints
Table 16. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Players (2016-2021)
Table 18. Global Top Molecular Diagnosis of Nasopharyngeal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma as of 2020)
Table 19. Ranking of Global Top Molecular Diagnosis of Nasopharyngeal Carcinoma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnosis of Nasopharyngeal Carcinoma Product Solution and Service
Table 23. Date of Enter into Molecular Diagnosis of Nasopharyngeal Carcinoma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kingmed Company Details
Table 64. Kingmed Business Overview
Table 65. Kingmed Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 66. Kingmed Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 67. Kingmed Recent Development
Table 68. Inmedi Company Details
Table 69. Inmedi Business Overview
Table 70. Inmedi Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 71. Inmedi Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 72. Inmedi Recent Development
Table 73. ApexHealth Company Details
Table 74. ApexHealth Business Overview
Table 75. ApexHealth Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 76. ApexHealth Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 77. ApexHealth Recent Development
Table 78. SinoMD Company Details
Table 79. SinoMD Business Overview
Table 80. SinoMD Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 81. SinoMD Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 82. SinoMD Recent Development
Table 83. Premed Company Details
Table 84. Premed Business Overview
Table 85. Premed Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 86. Premed Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 87. Premed Recent Development
Table 88. Annoroad Company Details
Table 89. Annoroad Business Overview
Table 90. Annoroad Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 91. Annoroad Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 92. Annoroad Recent Development
Table 93. Topgen Company Details
Table 94. Topgen Business Overview
Table 95. Topgen Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 96. Topgen Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 97. Topgen Recent Development
Table 98. Geneis Company Details
Table 99. Geneis Business Overview
Table 100. Geneis Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 101. Geneis Recent Development
Table 102. Unitedgene Company Details
Table 103. Unitedgene Business Overview
Table 104. Unitedgene Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 105. Unitedgene Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 106. Unitedgene Recent Development
Table 107. Easydiagnosis Company Details
Table 108. Easydiagnosis Business Overview
Table 109. Easydiagnosis Molecular Diagnosis of Nasopharyngeal Carcinoma Product
Table 110. Easydiagnosis Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021) & (US$ Million)
Table 111. Easydiagnosis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Molecular Diagnosis of Nasopharyngeal Carcinoma Report Years Considered
Figure 11. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Regions (2022-2027)
Figure 15. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Players in 2020
Figure 16. Global Top Molecular Diagnosis of Nasopharyngeal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Nasopharyngeal Carcinoma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue in 2020
Figure 18. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Diagnosis of Nasopharyngeal Carcinoma Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type (2016-2027)
Figure 22. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application (2016-2027)
Figure 23. North America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Country (2016-2027)
Figure 24. United States Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type (2016-2027)
Figure 28. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application (2016-2027)
Figure 29. Europe Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Country (2016-2027)
Figure 30. Germany Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Region (2016-2027)
Figure 40. China Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Diagnosis of Nasopharyngeal Carcinoma Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kingmed Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 60. Inmedi Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 61. ApexHealth Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 62. SinoMD Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 63. Premed Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 64. Annoroad Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 65. Topgen Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 66. Geneis Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 67. Unitedgene Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 68. Easydiagnosis Revenue Growth Rate in Molecular Diagnosis of Nasopharyngeal Carcinoma Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…- 世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gallbladder cancer Market Analysis and Insights: Global Molecular Diagnosis of Gallbladder Cancer Market The global Molecular Diagnosis of Gallbladder Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
- 世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing hereditary colorectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Hereditary Colorectal Cancer Market The global Molecular Diagnosis of Hereditary Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の結核分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing tuberculosis Market Analysis and Insights: Global Molecular Diagnosis of Tuberculosis Market The global Molecular Diagnosis of Tuberculosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
- 世界の食道がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing esophageal cancer Market Analysis and Insights: Global Esophageal Cancer Molecular Diagnosis Market The global Esophageal Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021…